And indeed, in some areas, particularly in oncology, there is scientific progress being made in precision medicine. But in ...

Despite several recent advancements in the field of prostate cancer (PC) treatment, there remain distinct gaps in the current ...

In this episode of our Frontiers Health limited series of the pharmaphorum podcast, Deep Dive editor Eloise McLennan speaks ...

Having already voted unanimously that all pregnant women should be tested for hepatitis B as a precursor to deciding an HBV ...

Biogen has reached a deal to buy Alcyone Therapeutics, a privately held company that has developed a system for delivering ...

UK medtech firm Closed Loop Medicine has launched its first product in the US, a digital tool for personalising the dose of ...

The UK's Royal College of Psychiatrists (RCPsych) has published a report that calls for more clinical testing of psychedelic ...

Panellists voted by 8 to 3 – with one abstention – to change the CDC recommendations to state that MMRV is not recommended ...

Newly launched ophthalmology company Ollin Biosciences has emerged onto the scene with $100 million in backing and a mission to bring a rival drug for wet age-related macular degeneration (AMD) that ...

In today's pharmaphorum podcast, host Jonah Comstock speaks with Alice Valder Curran, a partner at Hogan Lovells and our ...

There is only one approved drug for ultra-rare disease fibrodysplasia ossificans progressiva (FOP) on the US market, but ...

Dr Susan Monarez told lawmakers today that Health and Human Services (HHS) Secretary Robert F Kennedy Jr said he planned to ...